226 related articles for article (PubMed ID: 20169198)
21. HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir.
Yasutake Y; Hattori SI; Hayashi H; Matsuda K; Tamura N; Kohgo S; Maeda K; Mitsuya H
Sci Rep; 2018 Jan; 8(1):1624. PubMed ID: 29374261
[TBL] [Abstract][Full Text] [Related]
22. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of the entecavir-resistance-inducing mutation rtA186T in a large cohort of Chinese hepatitis B virus patients.
Liu L; Liu Y; Chen R; Li X; Luo D; Zhao Y; Li Q; Huang B; Wang FS; Liu X; Xu D
Antiviral Res; 2019 Apr; 164():131-138. PubMed ID: 30796932
[TBL] [Abstract][Full Text] [Related]
24. Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase.
Domaoal RA; McMahon M; Thio CL; Bailey CM; Tirado-Rives J; Obikhod A; Detorio M; Rapp KL; Siliciano RF; Schinazi RF; Anderson KS
J Biol Chem; 2008 Feb; 283(9):5452-9. PubMed ID: 17962184
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy.
Zhang Y; He S; Li QL; Guo JJ
Virus Res; 2013 Nov; 177(2):156-62. PubMed ID: 23968804
[TBL] [Abstract][Full Text] [Related]
26. A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B.
Doğan ÜB; Öztürk AB; Akın MS; Yalaki S; Sayan M
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():206-9. PubMed ID: 25910308
[TBL] [Abstract][Full Text] [Related]
27. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
Sayan M; Hülagü S; Akhan SC; Sentürk O; Meriç M; Cekmen M
Mikrobiyol Bul; 2009 Jul; 43(3):425-32. PubMed ID: 19795617
[TBL] [Abstract][Full Text] [Related]
28. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.
Delaney WE; Yang H; Westland CE; Das K; Arnold E; Gibbs CS; Miller MD; Xiong S
J Virol; 2003 Nov; 77(21):11833-41. PubMed ID: 14557667
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of an entecavir-resistant hepatitis B virus variant.
Yatsuji H; Hiraga N; Mori N; Hatakeyama T; Tsuge M; Imamura M; Takahashi S; Fujimoto Y; Ochi H; Abe H; Maekawa T; Suzuki F; Kumada H; Chayama K
J Med Virol; 2007 Dec; 79(12):1811-7. PubMed ID: 17935165
[TBL] [Abstract][Full Text] [Related]
30. 7-Deaza-7-fluoro modification confers on 4'-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety.
Hayashi S; Higashi-Kuwata N; Das D; Tomaya K; Yamada K; Murakami S; Venzon DJ; Hattori SI; Isogawa M; Sarafianos SG; Mitsuya H; Tanaka Y
Antiviral Res; 2020 Apr; 176():104744. PubMed ID: 32084506
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous emergence of entecavir resistance mutations in a nucleoside-naive chronic hepatitis B patient.
Lee HW; Kim HJ; Hong SP; Cha BK; Chang HY; Choi CH; Do JH; Kim JG; Chang SK
Intervirology; 2012; 55(5):380-4. PubMed ID: 22538265
[TBL] [Abstract][Full Text] [Related]
32. Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs.
Liu Y; Chen R; Liu W; Si L; Li L; Li X; Yao Z; Liao H; Wang J; Li Y; Zhao J; Xu D
Antiviral Res; 2021 May; 189():105058. PubMed ID: 33711338
[TBL] [Abstract][Full Text] [Related]
33. 4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.
Takamatsu Y; Tanaka Y; Kohgo S; Murakami S; Singh K; Das D; Venzon DJ; Amano M; Higashi-Kuwata N; Aoki M; Delino NS; Hayashi S; Takahashi S; Sukenaga Y; Haraguchi K; Sarafianos SG; Maeda K; Mitsuya H
Hepatology; 2015 Oct; 62(4):1024-36. PubMed ID: 26122273
[TBL] [Abstract][Full Text] [Related]
34. Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance.
Ahn SH; Kim DH; Lee AR; Kim BK; Park YK; Park ES; Ahn SH; Shin GC; Park S; Kang HS; Rhee JK; Yang SI; Chong Y; Kim KH
PLoS One; 2015; 10(8):e0136728. PubMed ID: 26322642
[TBL] [Abstract][Full Text] [Related]
35. Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine.
Geipel A; Seiz PL; Niekamp H; Neumann-Fraune M; Zhang K; Kaiser R; Protzer U; Gerlich WH; Glebe D;
Antivir Ther; 2015; 20(8):779-87. PubMed ID: 25560463
[TBL] [Abstract][Full Text] [Related]
36. Understanding the molecular basis of HBV drug resistance by molecular modeling.
Sharon A; Chu CK
Antiviral Res; 2008 Dec; 80(3):339-53. PubMed ID: 18765256
[TBL] [Abstract][Full Text] [Related]
37. Impacts of HBV rtH55R polymerase substitution on viral replication and rtM204I/V resistance to nucleoside/nucleotide antiviral drugs.
Xiang KH; Zhao CY; Wang S; Li Y; Su MZ; Wang QY; Xu XZ; Deng J; Zhuang H; Li T
Antivir Ther; 2018; 23(1):33-42. PubMed ID: 28440785
[TBL] [Abstract][Full Text] [Related]
38. Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir.
Karatayli E; Idilman R; Karatayli SC; Cevik E; Yakut M; Seven G; Kabaçam G; Bozdayi AM; Yurdaydin C
Antivir Ther; 2013; 18(1):77-85. PubMed ID: 22878399
[TBL] [Abstract][Full Text] [Related]
39. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
Ogata N; Ichida T; Aoyagi Y; Kitajima I
Rinsho Byori; 2003 Apr; 51(4):313-9. PubMed ID: 12747252
[TBL] [Abstract][Full Text] [Related]
40. Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
Xu Z; Liu Y; Xu T; Chen L; Si L; Wang Y; Ren X; Zhong Y; Zhao J; Xu D
J Clin Virol; 2010 Aug; 48(4):270-4. PubMed ID: 20580309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
